Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting 7 Questions About Clinical Evaluations for MDR By Janet Kube March 2, 2018 Consulting Europe’s Medical Device Regulation: Get to Know the Basics By Janet Kube February 22, 2018 Data Management & Biostatistics ICH GCP Update: Sponsor Control of Clinical Trial Data By Premier Research February 14, 2018 Data Management & Biostatistics Beyond Meltdown and Spectre: Our Take on IT Security By Brian Kachel February 6, 2018 Global Compliance Updates to the ICH GCP (Good Clinical Practice) Guidelines: Quick Review By Premier Research January 31, 2018 Patient and Stakeholder Engagement AD Trials: Three routes to increasing enrollment By Sebastian Turek January 18, 2018 Previous 1 …34 35 36 37 38 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today